Advances and Challenges in Nanodelivery Systems for RNA Vaccines
ACS Nano · 01.09.2026 · 20 (34) · 23649-23695
DOI: 10.1021/acsnano.6c10327 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Nano, online erschienen am 14.08.2026. Verfasst von Hang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Inn…. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Nucleic Acid-Based Vaccines, Nanoparticle Drug Delivery System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 427 Literaturangaben. Gefördert von: National Science and Technology Major Project, National Basic Research Program of China (973 Program), National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
RNA vaccines have become a transformative technology in infectious disease prevention and cancer treatment, thanks to their rapid development, high immunogenicity, and scalability in production. However, the clinical application of RNA vaccines faces significant challenges, including the inherent instability and susceptibility to degradation of naked RNA, its poor permeability across cell membranes, and the potential for nonspecific immune responses following systemic administration. Nanodelivery systems are key to addressing these challenges; by providing physical protection, enabling targeted delivery, promoting cellular uptake, and facilitating escape from endosomes, they significantly enhance the efficacy and safety of RNA vaccines. This review provides a comprehensive overview of the latest advances in nanodelivery systems for RNA vaccines, focusing on the characteristics of three distinct types of RNA vaccines─linear mRNA, self-amplifying RNA, and circular RNA─as well as the applications of lipid nanoparticles, polymeric nanoparticles, virus-like particles, and other emerging nanocarriers in enhancing RNA stability, boosting immunogenicity, and enabling precise targeting. Furthermore, this study will examine the key challenges in this field, including vector biosafety, large-scale production, cost-effectiveness, and storage and transportation, and will also outline future research directions and prospects for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University,…
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu610041, China.
ORCID-Profile: Hang Li, Aiping Tong
Förderung
- National Science and Technology Major Project
- National Basic Research Program of China (973 Program)
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Li, H., Zhao, Y., Yang, J., Guo, J., Cai, H., & Tong, A. (2026). Advances and Challenges in Nanodelivery Systems for RNA Vaccines. ACS Nano, 20(34), 23649-23695. https://doi.org/10.1021/acsnano.6c10327
Vancouver
Li H, Zhao Y, Yang J, Guo J, Cai H, Tong A. Advances and Challenges in Nanodelivery Systems for RNA Vaccines. ACS Nano. 2026;20(34):23649-23695. doi:10.1021/acsnano.6c10327
BibTeX
@article{Li2026,
author = {Li, Hang and Zhao, Yubo and Yang, Jiajun and Guo, Jinqiao and Cai, Hao and Tong, Aiping},
title = {Advances and Challenges in Nanodelivery Systems for RNA Vaccines},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {34},
pages = {23649--23695},
doi = {10.1021/acsnano.6c10327}
}
EUVIMED